Velasco Marta M

Show results for

Genomics (6)
Unknown (4)
Metabolomics (2)

Organisms

Homo sapiens (6)

Repository

EGA (6)
MetaboLights (2)

Technology Type

Illumina Genome Analyzer II, Affymetrix snp 6.0, Illumina Genome Analyzer IIx, GPL570, Affymetrix GeneChip Human Genome U133 plus 2.0 (1)
Mass spectrometry (1)
Mass spectrometry assay (1)

Instrument Platform

Liquid Chromatography MS - (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2026 (1)
2025 (1)

CHEBI ID

CHEBI:116314 (2)
CHEBI:137096 (2)
CHEBI:137098 (2)
CHEBI:137124 (2)
CHEBI:137125 (2)
CHEBI:30769 (2)
CHEBI: 132244 (1)
CHEBI: 136531 (1)
CHEBI: 15354 (1)
CHEBI: 15603 (1)
CHEBI: 15903 (1)
CHEBI: 15937 (1)
CHEBI: 16015 (1)
CHEBI: 16708 (1)
CHEBI: 16821 (1)
CHEBI: 16857 (1)
CHEBI: 173454 (1)
CHEBI: 174796 (1)
CHEBI: 17895 (1)
CHEBI: 20912 (1)
CHEBI: 27506 (1)
CHEBI: 28794 (1)
CHEBI: 28873 (1)
CHEBI: 32525 (1)
CHEBI: 33076 (1)
CHEBI: 38257 (1)
CHEBI: 58670 (1)
CHEBI: 6031 (1)
CHEBI: 74475 (1)
CHEBI: 75575 (1)

Metabolite Name

3-Benzyl-2-methyl-2-tridecanamine (2)
3-Hexenyl salicylic acid (2)
Coumarin (2)
Heptadecasphinganine (2)
Hexadecylamine (2)
Lysophosphatidilcholine (2)
Myristamide (2)
(E)-N-(2-(((3-(4-Chlorophenyl)allyl)(methyl)amino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide (1)
(Z)-1,3-Octadiene (1)
1,2-Benzenedithiol (1)
1,7-Octadiene (1)
1-Acetoxy-2-hydroxy-16-heptadecyn-4-one (1)
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (1)
2,3-Dihidro-1H-indol (1)
2,3-Dihydro-1H-pyrrolizine-5-carboxaldehyde (1)
2-(3-Phenylpropyl)tetrahydrofuran (1)
2-Acetyl-6-methylpyridine (1)
2-Nonenal, 4-oxo- (1)
2-Phenylpropionaldehyde dimethyl acetal (1)
3,3'-Iminodipropionitrile (1)
3,4-dimethylaniline (1)
3,5,7-Octatriyn-1-ol (1)
3-Benzyl-2-methyl-2-pentadecanamine (1)
3-Hexylpyridine (1)
3-Phenylpropyl glucosinolate (1)
3-benzyl-2-methyl-2-pentadecanamine (1)
3-pentylpyridine (1)
4-Oxoproline (1)
5-p-Coumaroylquinic acid (1)
8-Acetoxy-4'-methoxypinoresinol 4-glucoside (1)

Release Date

2022 (2)
2021 (1)
2020 (1)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Untargeted Metabolomics of Brassica oleracea under Oleamide Supplementation: Resistance-Associated Changes

Oleamide, a fatty acid amide with potential bioactive properties against Xanthomonas campestris pv. campestris (Xcc), was evaluated for its impact on the metabolome of Brassica oleracea. Susceptible 'Early Big' plants at six weeks of age were pretreated with 60 µM oleamide. Twenty-four hours afte...

2026-03-13 | MTBLS12902 | MetaboLights

Diurnal Dynamics Shape Plant Defense Responses: Temporal Variations in Disease Progression and Metabolic Reprogramming in Brassica oleracea

Plants synchronize their immune responses with the circadian cycle, yet the impact of diurnal timing on disease resistance remains poorly understood in crop species. In this study, we investigated how diurnal variation modulates defense responses in Brassica oleracea against Xanthomonas campestris p...

2025-08-22 | MTBLS7854 | MetaboLights

EGAS00000000092-ega-27092011 - samples

Recurrent Somatic Mutations in CLL

EGAD00001000044 | EGA

EGAS00000000092-ega-20110419 2 - samples

Recurrent Somatic Mutations in CLL

EGAD00001000023 | EGA

EGAD00010000280

CLL Expression array

EGAD00010000280 | EGA

EGAD00010000238

CLL Expression array

EGAD00010000238 | EGA

20ExonArrays_EGAS00000000092 - samples

CLL Expression Array

EGAD00010000470 | EGA

CLL Genome

The Chronic Lymphocytic Leukemia (CLL) Genome Project aims to identify genetic alterations involved in the development and progression of the CLL, which are still unknown, with the objective of generating a comprehensive catalogue of genetic alterations in 500 independent tumours. The CLL Genome Pro...

EGAS00000000092 | EGA

Characterisation of the blood RNA host response underpinning severity in COVID-19 patients.

Not available

S-EPMC9288817 | biostudies-literature

Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with multimorbidity and polypharmacy aimed at improving prescribing practices in primary care: study protocol of a cluster randomized trial.

Not available

S-EPMC9178530 | biostudies-literature